Epigenetic-based combination therapy and liposomal codelivery overcomes osimertinib-resistant NSCLC via repolarizing tumor-associated macrophages
Tingting Lin, Wei Xiong, Guihua Chen, Yang He, Long Li, Xinfu Gao, Jialin Zhou, Wenwen Lv, Yongzhuo Huang
Topics & Concepts
OsimertinibMedicineCancer researchCombination therapyAngiogenesisEpigeneticsImmunotherapyPanobinostatCancerHistone deacetylasePharmacologyBiologyAdenocarcinomaHistoneInternal medicineGeneBiochemistryROS1Lung Cancer Treatments and MutationsLung Cancer Research StudiesEpigenetics and DNA Methylation